Dr. Miguel Cajipe

Dr. Miguel Cajipe
Miguel Cajipe MD returned to the East Valley to join Ironwood Urology. He was born in raised in Manila, Philippines and eventually moved to Chandler in 2005. He pursued his undergraduate studies in Biomedical Engineering at the University of Iowa where he was on the Dean’s List and President’s List for numerous semesters before graduating with Highest Distinction. His medical training started at Baylor College of Medicine in Houston where his interest in Urology started as a medical student. Eventually, he completed a 5-year residency at UT Health Urology in San Antonio receiving several accolades for his dedication to resident and medical student education along the way. Dr. Cajipe treats all aspects of general urology in both men and women. He is interested in kidney stones, prostatic enlargement, as well as urologic cancer and is trained in open, laparoscopic, and robotic surgery. During his training, he was able to publish research in male infertility, bladder cancer, and renal cancer. Dr. Cajipe prides himself not only in his patient care and surgical skills but also in his bedside manner. When he is not taking care of patients, Dr. Cajipe enjoys being active with weight training as well as sports like volleyball and dodgeball. He takes care of an 85-lb goldendoodle and loves to bake bread on the weekends. He is excited to be back in Arizona with his family and is looking forward to taking care of patients with his colleagues at Ironwood Urology. Dr. Cajipe sees patients at the Ironwood Urology Phoenix office which is a division of Ironwood Physicians.
Medical School:

Baylor College of Medicine


UT Health Urology (San Antonio)

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only